The association of RON with MET and EGFR has been investigated by immunoprecipitation and cross-linking experiments, demonstrating receptor transphosphorylation, which may play a role in predicting therapeutic response and drug resistance in breast cancer [26, 29, 30]. The gene discussed is MET; the disease is breast carcinoma.